GLA

Faculty

Dr. Himanshu Gupta

Associate Professor - Institute of Applied Sciences & Humanities

Department

Department of Biotechnology

Experience

10 Years

Dr. Himanshu Gupta

Ph.D Thesis Supervised

4

Working

Postgraduate Thesis Supervised

6

Awarded/
Completed

2

Working

Qualifications

  • Ph.D. (Biotechnology; 2010 – 2015), School of Life Science (SOLS), Manipal University, India.
  • MSc. (Animal Biotechnology; 2007 - 2009), Department of Animal Biotechnology, University of Hyderabad, India.
  • BSc. (Medical Laboratory Technology; 2003 -

Publication

−
  • Kumar C, Bharti, PK, Gupta H*. Plasmodium vivax Malaria in India: Microbiological Barriers to Diagnosis, Treatment, and Elimination. Clin Microbiol Rev. ACCEPTED, June 2026. *Corresponding author IF=19.3
  • Ahmad A, Nema S, Krishna S, Gupta H, A Singh, Verma AK, Singh MP, Anvikar AR, Bharti PK. Comparative evaluation of Plasmodium falciparum glutamate dehydrogenase with known Plasmodium falciparum diagnostic targets using quantitative real-time polymerase chain reaction. J Vector Borne Dis. 2026 May 27. Accepted. IF=1.2
  • Ranjha R, Gupta A, Singh K, Sikka R, Anvikar AR, Gupta H*, Bharti, PK. Mechanistic insights into subclinical Plasmodium infections: Unveiling the silent drivers of malaria transmission. iScience, 2026; 29. *Corresponding author IF=4.1
  • Bhandari S, Krishna S, Verma AK, Ranjha R, Gupta H, Bharti PK. Differential IgG responses to PfHRP2 across the malaria severity spectrum. Trans R Soc Trop Med Hyg. 2026 Apr 9:trag034. IF=1.5
  • Arora K, Gupta M, Gupta H*, Sikka R. MicroRNAs as biomarkers and therapeutic targets in pterygia: A systematic review with quantitative synthesis. Surv Ophthalmol. 2026 Feb 4:S0039-6257(26)00015-9. *Corresponding author IF=5.9
  • Mahor Shivani, Gupta H*. Serratia Species as Paratransgenic Vehicles: Potential Applications in Vector-Borne Disease Control. Clin Microbiol Rev. 2026 Feb 2:e0028025. *Corresponding author IF=19.3
  • Gupta A, Gupta H*. Functional evidence of hsa-miR-21-5p and hsa-miR-3158-3p in regulating immune pathways relevant to cerebral malaria. Mol Biol Rep 53, 300 (2026). *Corresponding author. IF=2.8
  • Ahmad A, Nema S, Arora K, Sikka R, Singh A, Krishna S, Singh MP, Verma AK, Nitika N, Anvikar AR, Gupta H, Bharti PK. Evaluation of GDH and HDP as novel serological biomarkers for Plasmodium falciparum malaria diagnosis across varying parasitemia and transmission settings in India. PLoS One. 2025 Oct 15;20(10):e0334313. IF=2.6
  • Gupta A, Gupta H*. Can India–Africa Synergies Accelerate Malaria Elimination? A Perspective on South–South Collaboration. J Vector Borne Dis. 2025 Aug 29. *Corresponding author. IF=1.2
  • Gupta A, Arora K, Bhandari S, Sikka R, Wassmer SC, Bharti PK, Gupta H*. Potential of microRNAs as diagnostic markers for distinguishing malaria severity in samples from an Indian cohort. BMC Infect Dis 25, 1065 (2025). *Corresponding author. IF=3.0
  • Prabhua RS, Paul S, Umakanth S, Hande M, Saadi VA, Gupta H, Satyamoorthy K. Deciphering the potential of miRNA-92a-3p as lead for sequence-based therapies for malaria. Acta Parasitol. 2025 Aug 11;70(4):179. IF=1.5
  • Gupta H, Barde P, Singh M, Bharti P, Nitika N. Arboviral diseases in India: A comprehensive overview of burden, prevention, and therapeutic aspects. Commun Med (Lond). 2025 Jul 1;5(1):254. IF=6.3
  • Varo R, Sitoe A, Madrid L, Aide P, Cuamba I, Cossa A, Jairoce C, Barrios D, Martiáñez-Vendrell X, Balanza N, Cistero P, Ouchi D, Quintó L, Crowley VM, Gupta H, Kain K, Mayor A, Bassat Q. Host biomarkers and parasite biomass are associated with severe malaria in Mozambican children: a case–control study. Scientific Reports, Sci Rep. 2025 Apr 24;15(1):14262. IF=3.9
  • Gupta H, Anvikar AR, Bharti PK. Building Momentum for a Malaria Free India. Am J Trop Med Hyg. 2025 Apr 1;112(6):1193-1195. IF=1.6
  • Gupta M, Arya S, Agrawal P, Gupta H*, Sikka R. Unravelling the molecular tapestry of pterygium: insights into genes for diagnostic and therapeutic innovations. Eye (Lond). 2024 Jun 21. *Corresponding author IF=3.4
  • Gupta H*, Sharma S, Gilyazova I, Satyamoorthy K. Molecular tools are crucial for malaria elimination. Mol Biol Rep. 2024 Apr 20;51(1):555. *Corresponding author IF=2.8
  • Upadhayay P, Singh N, Pandey M, Gupta H, Sikka R. Unveiling the link between lifestyle risk factors and diabetic retinopathy. International Journal of Diabetes in Developing Countries, 2024, 1-6. IF=0.9
  • Gilyazova I, Ivanova E, Gupta H, Mustafin A, Ishemgulov R, Izmailov A, Gilyazova G, Pudova E, Pavlov V, Khusnutdinova E. miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis. Biomedicines. 2023; 11(11):3073. IF=3.9
  • Gupta A, Skjefte M, Muppidi P, Sikka R, Pandey M, Bharti PK, Gupta H*. Unravelling the Influence of Host Genetic Factors on Malaria Susceptibility in Asian Populations. Acta Tropica. 2024, 249:107055. *Corresponding author. IF=2.5
  • Sikka R, Raina P, Soni R, Gupta H, Bhanwer AJS. Genomic profile of diabetic retinopathy in a north Indian cohort. Mol Biol Rep (2023). https://doi.org/10.1007/s11033-023-08772-z. IF=2.8
  • Gilyazova I, Asadullina D, Kagirova E, Sikka R, Mustafin A, Ivanova E, Bakhtiyarova K, Gilyazova G, Gupta S, Khusnutdinova E, Gupta H, Pavlov V. MiRNA-146a-A Key Player in Immunity and Diseases. Int J Mol Sci. 2023 Aug 14;24(16):12767. IF=4.9
  • Mukhi B, Gupta H, Punnath K, Anvikar AR, Srivastava B, Ghosh SK. Artemisinin-based combination therapy successfully treated two hyperparasitaemic Plasmodium falciparum cases. J Infect Dev Ctries. 2023 May 31;17(5):725-731. IF=1.2
  • Muppidi P, Wright E, Wassmer SC, Gupta H*. Diagnosis of cerebral malaria: Tools to reduce Plasmodium falciparum associated mortality. Frontiers in Cellular and Infection Microbiology. 2023. 13, 95. *Corresponding author. IF=4.8
  • Gupta H, Nema S, Bharti PK. Time to stimulate Plasmodium vivax research in India: A way forward. Asian Pacific Journal of Tropical Medicine. 2023; 16(1), 1-2. IF=1.6
  • Martiáñez-Vendrell X, Skjefte M, Sikka R, Gupta H*. Factors Affecting the Performance of HRP2-Based Malaria Rapid Diagnostic Tests. Trop Med Infect Dis. 2022 Sept 25;7(10):265. *Corresponding author. IF=2.6
  • Mohanty S, Sahu PK, Pattnaik R, Majhi M, Maharana S, Bage J, Mohanty A, Mohanty A, Bendszus M, Patterson C, Gupta H, Dondorp AM, Pirpamer L, Hoffmann A, Wassmer SC. Evidence of Brain Alterations in Noncerebral Falciparum Malaria. Clin Infect Dis. 2022 Aug 24;75(1):11-18. IF=7.3
  • Sikka R, Bharti PK, Gupta H*. microRNAs: An opportunity to overcome significant challenges in malaria detection and control. Curr Res Pharmacol Drug Discov. 2022;3:100115. *Corresponding author
  • Gupta H*, Wassmer SC*. Harnessing the Potential of miRNAs in Malaria Diagnostic and Prevention. Front Cell Infect Microbiol. 2021;11:793954. *Corresponding authors. IF=4.8
  • Sahu PK, Hoffmann A, Majhi M, Pattnaik R, Patterson C, Mahanta KC, Mohanty AK, Mohanty RR, Joshi S, Mohanty A, Bage J, Maharana S, Seitz A, Bendszus M, Sullivan SA, Turnbull IW, Dondorp AM, Gupta H, Pirpamer L, Mohanty S, Wassmer SC. Brain Magnetic Resonance Imaging Reveals Different Courses of Disease in Pediatric and Adult Cerebral Malaria. Clin Infect Dis. 2021 Oct 5;73(7):e2387-e2396. IF=7.3
  • Raina P, Sikka R, Gupta H, Matharoo K, Bali SK, Singh V, Bhanwer A. Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study. Biochem Genet. 2021 Aug;59(4):966-996. IF=1.6
  • Gupta H*, Sahu PK, Pattnaik R, Mohanty A, Majhi M, Mohanty AK, Pirpamer L, Hoffmann A, Mohanty S, Wassmer SC*. Plasma levels of hsa-miR-3158-3p microRNA on admission correlate with MRI findings and predict outcome in cerebral malaria. Clin Transl Med. 2021 Jun;11(6):e396. *Corresponding authors. IF=6.8
  • Gupta H*, Rubio M, Sitoe A, Varo R, Cisteró P, Madrid L, Cuamba I, Jimenez A, Martiáñez-Vendrell X, Barrios D, Pantano L, Brimacombe A, Bustamante M, Bassat Q, Mayor A. Plasma MicroRNA Profiling of Plasmodium falciparum Biomass and Association with Severity of Malaria Disease. Emerg Infect Dis. 2021 Feb;27(2):430-442. *Corresponding author. IF=6.6
  • Galatas B, Mayor A, Gupta H, Balanza N, Jang IK, Nhamussua L, Simone W, Cisteró P, Chidimatembue A, Munguambe H, Saúte F, Aide P, Bassat Q. Field performance of ultrasensitive and conventional malaria rapid diagnostic tests in southern Mozambique. Malar J. 2020 Dec 7;19(1):451. IF=3.0
  • Mukhi B, Gupta H*, Wassmer SC, Anvikar AR, Ghosh SK. Haplotype of RNASE 3 polymorphisms is associated with severe malaria in an Indian population. Mol Biol Rep. 2020 Nov;47(11):8841-8848. *Corresponding author. IF=2.8
  • Gupta H, Galatas B, Chidimatembue A, Huijben S, Cisteró P, Matambisso G, Nhamussua L, Simone W, Bassat Q, Ménard D, Ringwald P, Rabinovich NR, Alonso PL, Saúte F, Aide P, Mayor A. Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance. PLoS One. 2020;15(10):e0240174. IF=2.6
  • Huijben S, Macete E, Mombo-Ngoma G, Ramharter M, Kariuki S, Desai M, Shi YP, Mwangoka G, Massougbodji A, Cot M, Ndam NT, Uberegui E, Gupta H, Cisteró P, Aponte JJ, González R, Menéndez C, Mayor A. Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy. J Infect Dis. 2020 Jan 2;221(2):293-303. IF=4.5
  • Anvikar AR, van Eijk AM, Shah A, Upadhyay KJ, Sullivan SA, Patel AJ, Joshi JM, Tyagi S, Singh R, Carlton JM, Gupta H*, Wassmer SC*. Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India. Virulence. 2020 Jan 1;11(1):730-738. *Corresponding authors. IF=5.4
  • Smith-Aguasca R, Gupta H, Uberegui E, Maquina M, Saute F, Paaijmans KP, Mayor A, Huijben S. Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum. Malar J. 2019 Oct 17;18(1):351. IF=3.0
  • Fonseca AM, González R, Bardají A, Jairoce C, Rupérez M, Jiménez A, Quintó L, Cisteró P, Vala A, Sacoor C, Gupta H, Hegewisch-Taylor J, Brew J, Ndam NT, Kariuki S, López M, Dobaño C, Chitnis CE, Ouma P, Ramharter M, Abdulla S, Aponte JJ, Massougbodji A, Briand V, Mombo-Ngoma G, Desai M, Cot M, Nhacolo A, Sevene E, Macete E, Menéndez C, Mayor A. VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy. Emerg Infect Dis. 2019 Oct;25(10):1851-1860. IF=6.6
  • Gupta H*, Galatas B, Matambisso G, Nhamussua L, Cisteró P, Bassat Q, Casellas A, Macete E, Aponte JJ, Sacoor C, Alonso P, Saúte F, Guinovart C, Aide P, Mayor A. Differential expression of var subgroups and PfSir2a genes in afebrile Plasmodium falciparum malaria: a matched case-control study. Malar J. 2019 Sep 23;18(1):326. *Corresponding author. IF=3.0
  • Marco-Hernández J, Camprubí D, Aylagas C, Gupta H, Castro P. Failure of intravenous artesunate treatment for Plasmodium falciparum malaria in a splenectomized traveller: A diagnostic challenge. Travel Med Infect Dis. 2019 Jul-Aug;30:142-143. IF=4.7
  • Rodríguez-Valero N, Camprubí D, García-Guijarro E, Llenas-García J, Alejo-Cancho I, Cisteró P, Mayor A, Muñoz J, Gupta H*. Suspected quinine resistant P. falciparum severe malaria possibly acquired in Ivory Coast. Parasitol Int. 2018 Dec;67(6):684-687. *Corresponding author. IF=1.9
  • Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, Ménard D, Ringwald P, Bassat Q, Enosse S, Mayor A. Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015. Emerg Infect Dis. 2018 Jan;24(1):40-48. IF=6.6
  • Martínez-Pérez G, Lansana DP, Omeonga S, Gupta H, Breeze-Barry B, González R, Bardají A, Sarukhan A, Goteh JDK, Tody E, Cisteró P, Benda B, Kercula JD, Kibungu FD, Meyer García-Sípido A, Bassat Q, Tarr-Attia CK, Mayor A. Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia. Malar J. 2018 Oct 11;17(1):357. IF=3.0
  • Gupta H, Matambisso G, Galatas B, Cisteró P, Nhamussua L, Simone W, Cunningham J, Rabinovich NR, Alonso P, Saute F, Aide P, Mayor A. Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique. Malar J. 2017 Oct 16;16(1):416. IF=3.0
  • Galatas B, Nhamussua L, Candrinho B, Mabote L, Cisteró P, Gupta H, Rabinovich R, Menéndez C, Macete E, Saute F, Mayor A, Alonso P, Bassat Q, Aide P. In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies. Sci Rep. 2017 May 2;7(1):1356. IF=3.9
  • Gupta H, Chaudhari S, Rai A, Bhat S, Sahu PK, Hande MH, D'Souza SC, Shashikiran U, Satyamoorthy K. Genetic and epigenetic changes in host ABCB1 influences malaria susceptibility to Plasmodium falciparum. PLoS One. 2017;12(4):e0175702. IF=2.6
  • Magallón-Tejada A, Machevo S, Cisteró P, Lavstsen T, Aide P, Rubio M, Jiménez A, Turner L, Valmaseda A, Gupta H, De Las Salas B, Mandomando I, Wang CW, Petersen JE, Muñoz J, Gascón J, Macete E, Alonso PL, Chitnis CE, Bassat Q, Mayor A. Cytoadhesion to gC1qR through Plasmodium falciparum Erythrocyte Membrane Protein 1 in Severe Malaria. PLoS Pathog. 2016 Nov;12(11):e1006011. IF=4.9
  • Gupta H, Dhunputh P, Bhatt AN, Satyamoorthy K, Umakanth S. Cerebral malaria in a man with Plasmodium vivax mono-infection: a case report. Trop Doct. 2016 Oct;46(4):241-245. IF=0.6
  • Gupta H, Srivastava S, Chaudhari S, Vasudevan TG, Hande MH, D'souza SC, Umakanth S, Satyamoorthy K. New molecular detection methods of malaria parasites with multiple genes from genomes. Acta Trop. 2016 Aug;160:15-22. IF=2.5
  • Gupta H, Afsal MP, Shetty SM, Satyamoorthy K, Umakanth S. Plasmodium vivax infection causes acute respiratory distress syndrome: a case report. J Infect Dev Ctries. 2015 Aug 29;9(8):910-3. IF=1.2
  • Gupta H, Jain A, Saadi AV, Vasudevan TG, Hande MH, D'Souza SC, Ghosh SK, Umakanth S, Satyamoorthy K. Categorical complexities of Plasmodium falciparum malaria in individuals is associated with genetic variations in ADORA2A and GRK5 genes. Infect Genet Evol. 2015 Aug;34:188-99. IF=2.6
  • Fernandes RC, Hasan M, Gupta H, Geetha K, Rai PS, Hande MH, D'Souza SC, Adhikari P, Brand A, Satyamoorthy K. Host genetic variations in glutathione-S-transferases, superoxide dismutases and catalase genes influence susceptibility to malaria infection in an Indian population. Mol Genet Genomics. 2015 Jun;290(3):1155-68. IF=2.1
  • Gupta H, Sakharwade SC, Angural A, Kotambail A, Bhat GK, Hande MH, D'Souza SC, Rao P, Kumari V, Saadi AV, Satyamoorthy K. Evidence for genetic linkage between a polymorphism in the GNAS gene and malaria in South Indian population. Acta Trop. 2013 Dec;128(3):571-7. IF=2.5
  • Saadi AV*, Gupta H*, Angural A, Dhanya SK, Mony S, Oberoi D, D'Souza SC, Sahoo RC, Hande MH, Gopinath PM, Satyamoorthy K. Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population. Infect Genet Evol. 2013 Dec;20:140-7. *equal contribution IF=2.6

Conferences / Seminar / Workshop

+
  • 2025: ASTMH 2025 Annual Meeting, Toronto, Canada | 9th to 13th Nov, 2025. “Differentially expressed miR-3158-3p microRNA in severe malaria: from discovery to validation.” Invited Oral presentation.
  • 2025: 15th Annual Conference of ISMOCD-2025, Delhi, India | 31st Jan to 2nd Feb, 2025. “Differentially expressed miR-3158-3p microRNA in severe malaria: from discovery to validation.” Invited Oral presentation.
  • 2024: 21st International Congress for Tropical Medicine and Malaria, Kuching, Malaysia | September 19 to 23, 2024. “Differentially expressed miR-3158-3p microRNA in severe malaria: from discovery to validation.” Oral presentation.
  • 2024: 32nd National Congress on Parasitology, Pune, India | October 3 to 5, 2024. “miR-3158-3p: A Key MicroRNA in Severe Malaria—From Discovery to Validation.” Invited Oral presentation.
  • 2023: Science of Defeating Malaria - A Leadership Course, Dakar, Senegal | June 18 to 23, 2023. Invited.
  • 2023: Malaria Gordon Conference 2023: Reinvigorating Malaria Control, Prevention and Treatment: From Bench to Bedside to Bednets, Rey Don Jaime Grand Hotel, Castelldefels, Barcelona, Spain | May 28 - June 2, 2023. Invited discussion leader.
  • 2021: Johns Hopkins Future of Malaria Research Symposium | 12 Nov 2021, Virtual conference. “Assessing the use of microRNA as biomarkers of severity in P. falciparum malaria infection.”
  • 2021: Malaria Centre Retreat, Newnham College, Cambridge | 20 - 21 September 2021. “Assessing the use of microRNA as biomarkers of severity in P. falciparum malaria infection.”
  • 2020: EMBL Conference: BioMalPar XVI: Biology and Pathology of the Malaria Parasite | 18 - 19 May 2020, Virtual conference. “Assessing the use of microRNA as biomarkers of severity in P. falciparum malaria infection.” Himanshu Gupta, Praveen K. Sahu, Rajyabardhan Pattnaik, Sanjib Mohanty, Samuel C. Wassmer. Poster presentation.
  • 2019: ASTMH 68th Annual Meeting, National Harbor, Maryland, USA | November 20-24, 2019. “Impact of Mass Drug Administration with Dihydroartemisinin-Piperaquine on P. falciparum Antimalarial Resistance and Gametocytaemia.” Himanshu Gupta, Beatriz Galatas, Arlindo Chidimatembue, Pau Cisteró, Gloria Matambisso, Carlos Ruiz-Arenas, Lidia Nhamussua, Silvie Huijben, Wilson Simone, Quique Bassat, Juan Ramon González, Baltazar Candrinho, N Regina Rabinovich, Pedro Alonso, Francisco Saute, Pedro Aide, Alfredo Mayor. Poster presentation (LB-5294).
  • 2017: Dept. de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Barcelona, Spain | March 2017. “Malaria: a story of the deadly disease”.
  • 2017: Keystone Symposium on “Malaria: From Innovation to Eradication”, Kampala, Uganda | 19 – 23 Feb, 2017. “Molecular surveillance of antimalarial and diagnostic resistance in Mozambican Plasmodium falciparum isolates: implications for elimination strategies.” Himanshu Gupta, Gloria Matambisso, Beatriz Galatas, Lidia Nhamussua, Wilson Simone, Quique Bassat, Pau Cisteró, Silvie Huijben, Eusébio Macete, Jane Cunningham, Didier Ménard, Pascal Ringwald, N Regina Rabinovitch, Pedro Alonso, Franciso Saute, Pedro Aide, Alfredo Mayor. Poster presentation.
  • 2016: Dept. de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Barcelona, Spain | May 2016. “Malaria: a story of the deadly disease”.
  • 2015: Gordon Research Conference: Translating Malaria Research to the Field, Girona, Spain | July 26-31, 2015. “Genetic and Epigenetic Variations may Influence Malaria Susceptibility.” Himanshu Gupta, Abdul Saadi Vahab, Manjunath H Hande, Sydney C D’Souza, K Satyamoorthy. Poster presentation.
  • 2015: National Institute of Immuno Haematology (ICMR), Mumbai, India: Genomics in Health and Disease & 40th annual conference of Indian Society of Human Genetics | January 28-30, 2015. “Genetic and Epigenetic Variations Can Influence Malaria Susceptibility.” Himanshu Gupta, Ayushi Rai, Manjunath H Hande, Sydney C D’Souza, Saadi Abdul Vahab, K Sataymoorthy. Poster presentation.
  • 2014: Manipal University, Manipal, India: Society of Biological Chemists (India) Coastal Karnataka Chapter symposium | October 25, 2014. “Genetic and Epigenetic variations in ABCB1 gene can modulate drugs response and malaria susceptibility.”
  • 2014: Manipal University, Manipal, India: Manipal Research Colloquium | 11th-12th April, 2014. “Variants of GNAS and ADRB2 Genes modulate Susceptibility of Malaria and Asthma diseases”.
  • 2013: Christ University, Bangalore: 6th Annual KSTA Conference: Science and Technology for Promoting Innovative Research and Development | December 21 and 22, 2013. “Variants of ADORA2A and GRK5 Genes modulate Susceptibility of Malaria in a South Indian Population”. Himanshu Gupta, Abdul Saadi Vahab, Manjunath H Hande, Sydney C D’Souza, PM Gopinath, K Satyamoorthy. Poster presentation.
  • 2013: Amrita Vishwa Vidyapeetham (University), Kollam: Amrita BioQuest-2013, International Conference on Biotechnology for Innovative Application | August 10-14, 2013. “Variants of ADORA2A and GRK5 Genes modulate Susceptibility of Malaria in a South Indian Population”. Himanshu Gupta, Abdul Saadi Vahab, Manjunath H Hande, Sydney C D’Souza, PM Gopinath, K Satyamoorthy. Poster presentation.
  • 2011: Participated in Manipal University, Manipal, India: Genomics, Genetic Diseases and Diagnostics | February 14-16, 2011.
  • 2010: Participated in “Short Term Training Programme on Designing and Synthesis of Peptide Antigens for Diagnosis” organized by Division of Animal Biotechnology, Indian Veterinary Research Institute, Bareilly | 10-17 February, 2010.
  • 2009: Participated in “International Conference on Novel Updates in Reproductive Biology and Comparative Endocrinology and The 27th Annual Meeting of the Society for Reproductive Biology and Comparative Endocrinology (SRBCE-XXVII)” at University of Hyderabad, Hyderabad | 18-21 September, 2009.
  • 2008: Participated in “EU-sponsored NanoBioSaccharides (NBS) Dissemination Conference” at University of Hyderabad, Hyderabad | 18-19 September, 2008.

Subjects Taught

+
Recombinant DNA Technology Virology Genomics and Proteomics

Research Interest

+
Dr. Gupta's expertise lies in integrating multi-omics, computational, and interdisciplinary approaches to dissect host–parasite interactions that drive diverse clinical manifestations of malaria and in translating these insights into robust biomarkers for early diagnosis and therapeutic interventions. He has strategically expanded this expertise to arboviral infections and pterygium, which are diseases of high regional relevance in the Braj region and of growing public health importance across India, thereby aligning advanced discovery science with local and national health priorities.

Funded Research Projects

+
  • SERB, New Delhi, India: Differentially Expressed miR-3158-3p MicroRNA in Severe Malaria: From Discovery to Validation. Funded Budget – ₹30,50,340/-, 2022–2024, Principal Investigator. Completed.
  • National Institutes of Health (NIH), USA: Centre for the Study of Complex Malaria in India – MicroRNAs-Based Biomarkers of Hidden Plasmodium Infections. Funded Budget – Approx. ₹82,00,000/-, 2024–2029, Principal Investigator. Ongoing.
  • GLA University, Mathura, India: Assessing the Use of MicroRNAs Involved in Regulating Immune Cells as Biomarkers of Severity in Plasmodium falciparum Infection. Funded Budget – ₹9,50,000/-, 2025–2027, Principal Investigator. Ongoing.

Others

+

MEMBERSHIPS

  • Royal Society of Biology, UK - Member elect (MRSB) (from January 2020)
  • American Society of Tropical Medicine and Hygiene, USA - Member elect (from January 2024)

EDITORIAL BOARD MEMBER

  • Scientific Reports (May/2024 – present)
  • BMC Infectious Diseases (March/2024 - present)
  • PLoS ONE (September/2022 - present)
  • Frontiers in Cellular and Infection Microbiology (April/2022 - present)
  • Journal of Applied Genetics (December/2020 - present)
  • Tropical Medicine and Infectious Disease (Aug/2020 - present)
  • Molecular Biology Reports Journal (Sep/2018 - present)

AWARDS

  • 2013: 1st prize for poster presentation at 6th Annual KSTA Conference: Science and Technology for Promoting Innovative Research and Development, Bangalore, India.
  • 2015: Young Scientist Award (travel and registration) from Science and Engineering Research Board (SERB) (Application No.- ITS/2259/2015-2016) to attend Gordon Research Conference and Seminar “Translating Malaria Research to the Field”, Girona, Spain.
  • 2016: Marie Curie Seal of Excellence by European Commission for Horizon 2020’s actions.
  • 2017: Bill and Melinda Gates Foundation Global Health Travel Award to attend Keystone Symposium on “Malaria: From Innovation to Eradication” in Kampala, Uganda.
  • 2017 - 2019: Overseas Postdoctoral Fellowship, Anusandhan National Research Foundation, New Delhi, India.
  • 2024: Senior Scientist Award from SERB, New Delhi, India (Application No.-ITS/2024/003451) to attend 21st International Congress for Tropical Medicine and Malaria, Kuching, Malaysia.

INTERNATIONAL THESIS SUPERVISION

  • 2025: Master thesis: Assessing distant organ effect on the brain during cerebral malaria using circulating microRNAs as surrogates - Victoria Cappleman (LSHTM, UK)
  • 2024: Post Master’s: Machine Learning Applications in microRNA Profiling for Early Detection of Malaria - Kushagri Arora (University of Amsterdam, The Netherlands)
  • 2023: Master thesis: miR-21 and miR-146a-5p as Potential Biomarkers for Severe Malaria in a Cohort of Indian Patients - Mikhela Saal (LSHTM, UK)
  • 2021: Master thesis: Investigating extracellular vesicle microRNAs derived from human brain endothelial cells after co-culturing with P. falciparum - Sabeeya Khan (LSHTM, UK)
  • 2021: Master thesis: Assessment of extracellular vesicle microRNA cargo as a potential tool for the diagnosis of malaria-associated ARDS - Pranavi Muppidi (LSHTM, UK)
  • 2020: Master thesis: The quest for diagnostic and prognostic markers in cerebral malaria - Emily Wright (LSHTM, UK)
  • 2018: Master thesis: Identification of Gene Targets of microRNAs to be used as Biomarkers in Severe Malaria - Allison Brimacombe (ISGlobal, Spain)

SOCIAL MEDIA PRESENCE

GLA Virtual Tour Admission Query

By submitting this form, I agree to receive notifications from the University in the form of SMS/E-mail/Call.

Graduate
  • B.Tech Programs
  • UG Programs
  • Lateral Entry
Post Graduate
  • M.Tech Programs
  • PG Programs
Doctoral
  • Doctoral Programs
Diploma
  • Diploma Programs
Admissions Helpline
Apply Online GLA
View All Contact Details GLA
Pay Online GLA
Programs
Admissions
Contact Us
Menu